Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells

Neal Flomenberg, John DiPersio, Gary Calandra

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Abstract

G-CSF mobilization of hematopoietic progenitor cells (HPCs) is mediated through enzyme release from maturing myeloid cells, leading to digestion of adhesion molecules, trophic chemokines and their receptors, and the extracellular matrix. HPCs traffic to and are retained in the marrow through the trophic effects of the chemokine SDF-1α/CXCL12 binding to its receptor, CXCR4. AMD3100 reversibly inhibits SDF-1α/CXCR4 binding, and AMD3100 administration mobilizes CD34+ cells into the circulation. AMD3100 has been tested in several clinical trials which demonstrate that it improves the number of CD34+ cells mobilized including patients failing to mobilize with G-CSF alone. Engraftment of AMD3100-mobilized cells is prompt and durable. Toxicities are mild and infrequent. Lymphoma and myeloma cells do not appear to be mobilized. AMD3100 appears to be a promising agent for HPC mobilization.

Original languageEnglish
Pages (from-to)198-205
Number of pages8
JournalActa Haematologica
Volume114
Issue number4
DOIs
StatePublished - Nov 2005

Keywords

  • Autotransplantation
  • CD34+ cell mobilization
  • CXCR4
  • Hematopoietic progenitor cell mobilization
  • SDF-1/CXCL12

Fingerprint

Dive into the research topics of 'Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells'. Together they form a unique fingerprint.

Cite this